Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant (Q34753416)
Jump to navigation
Jump to search
scientific article
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH-DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant |
scientific article |
|
Statements
1 reference
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant (English)
1 reference
Bladé J
1 reference
Samson D
1 reference
Reece D
1 reference
Apperley J
1 reference
Björkstrand B
1 reference
Gahrton G
1 reference
Gertz M
1 reference
Giralt S
1 reference
Jagannath S
1 reference
Vesole D
1 reference
1 September 1998
1 reference
1 reference
102
1 reference
1115-1123
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference